Form 4: USANA Health Sciences Director Acquires Shares Through Vesting of Restricted Stock Units

Director Gilbert A. Fuller acquired 674 shares of USANA Health Sciences common stock through the vesting of restricted stock units.

Summary

• Gilbert A. Fuller, a director at USANA Health Sciences, acquired 674 shares of common stock on February 2, 2025.
• This acquisition resulted from the vesting of restricted stock units.
• Each restricted stock unit converts to one share of USNA common stock.
• The restricted stock units vest in four tranches: 25% on August 2, 2024, November 2, 2024, February 2, 2025, and May 2, 2025.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to executive compensation, which is generally viewed neutrally to slightly positive as it aligns interests. There is no indication of any negative or unexpected events.

Positives

• The vesting of restricted stock units aligns director's interests with shareholders.
• The acquisition increases the director's stake in the company.

Industry Context

This is a routine transaction for a company that uses stock-based compensation as part of its executive compensation plan. It is common for directors to receive stock options or restricted stock units that vest over time.

Comparison to Industry Standards

• Many publicly traded companies use restricted stock units as part of their compensation packages for directors and executives.
• The vesting schedule of 25% per quarter is a fairly standard practice.
• Companies like Herbalife and Nu Skin also use similar stock-based compensation methods.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's performance.

Key Dates

Keywords

USANA Health Sciences, Director, Gilbert A. Fuller, Stock Acquisition, Restricted Stock Units, Vesting, Insider Trading, SEC Form 4